These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7248983)

  • 21. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
    Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
    Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of vindesine in advanced head and neck cancer.
    Cheng E; Young CW; Wittes RE
    Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial clinical studies of vindesine.
    Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
    Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
    In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vindesine in the treatment of esophageal carcinoma: a phase II study.
    Kelsen DP; Bains M; Cvitkovic E; Golbey R
    Cancer Treat Rep; 1979; 63(11-12):2019-21. PubMed ID: 526935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of metastatic breast cancer by navelbine, mitoxantrone and continuous infusion 5-fluorouracil (FMN regimen): results of a pilot study.
    Azim HA
    J Infus Chemother; 1996; 6(2):102-6. PubMed ID: 8809659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vindesine for recurrent and metastatic cancer of the uterine cervix: a phase II study.
    Rhomberg WU
    Cancer Treat Rep; 1986 Dec; 70(12):1455-7. PubMed ID: 3791258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of an intermittent schedule of dibromodulcitol in breast cancer.
    Tormey DC; Falkson G; Perlin E; Bull J; Blom J; Lippman ME
    Cancer Treat Rep; 1976 Nov; 60(11):1593-6. PubMed ID: 1035505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.
    Yap HY; Salem P; Hortobagyi GN; Bodey GP; Buzdar AU; Tashima CK; Blumenschein GR
    Cancer Treat Rep; 1978 Mar; 62(3):405-8. PubMed ID: 348308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I/II clinical trial of epirubicin and paclitaxel followed by granulocyte colony-stimulating factor in a 2-week schedule in patients with advanced or metastatic breast cancer.
    Ries F; Duhem C; Kleiber K; Dicato M
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-48-S17-51. PubMed ID: 9374093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I-II trial of a 5-day continuous infusion of vinblastine sulfate.
    Zeffren J; Yagoda A; Kelsen D; Winn R
    Anticancer Res; 1984; 4(6):411-3. PubMed ID: 6517534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vindesine in the treatment of malignant mesothelioma: a phase II study.
    Kelsen D; Gralla R; Cheng E; Martini N
    Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alternative treatment with carmustine, vindesine and tamoxifen in previously cytostaticly (VAC, FMC) treated patients with metastatic breast cancer].
    Massner B; Voss I; Queisser W; Drings P; Fritze D; Westerhausen M
    Onkologie; 1982 Aug; 5 Suppl():46-51. PubMed ID: 6752791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vincristine by continuous infusion in refractory breast cancer: a phase II study.
    Hopkins JO; Jackson DV; White DR; Muss HB; Richards F; Cooper MR; Stuart JJ; Sparr CL; Wells HB
    Am J Clin Oncol; 1983 Oct; 6(5):529-32. PubMed ID: 6613919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of 5-day vinblastine infusion in the treatment of patients with advanced refractory breast cancer.
    Tannock I; Erlichman C; Perrault D; Quirt I; King M
    Cancer Treat Rep; 1982 Sep; 66(9):1783-4. PubMed ID: 7116356
    [No Abstract]   [Full Text] [Related]  

  • 40. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
    Shibuya M; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.